332 related articles for article (PubMed ID: 22956186)
1. Notch signaling regulates tumor-induced angiogenesis in SPARC-overexpressed neuroblastoma.
Gorantla B; Bhoopathi P; Chetty C; Gogineni VR; Sailaja GS; Gondi CS; Rao JS
Angiogenesis; 2013 Jan; 16(1):85-100. PubMed ID: 22956186
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.
Chetty C; Lakka SS; Bhoopathi P; Kunigal S; Geiss R; Rao JS
Cancer Res; 2008 Jun; 68(12):4736-45. PubMed ID: 18559520
[TBL] [Abstract][Full Text] [Related]
3. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.
Boyineni J; Tanpure S; Gnanamony M; Antony R; Fernández KS; Lin J; Pinson D; Gondi CS
Int J Oncol; 2016 Oct; 49(4):1394-406. PubMed ID: 27498840
[TBL] [Abstract][Full Text] [Related]
4. Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis.
Cydzik M; Abdul-Wahid A; Park S; Bourdeau A; Bowden K; Prodeus A; Kollara A; Brown TJ; Ringuette MJ; Gariépy J
FASEB J; 2015 Aug; 29(8):3493-505. PubMed ID: 25921830
[TBL] [Abstract][Full Text] [Related]
5. Secreted protein acidic and rich in cysteine (SPARC) suppresses angiogenesis by down-regulating the expression of VEGF and MMP-7 in gastric cancer.
Zhang JL; Chen GW; Liu YC; Wang PY; Wang X; Wan YL; Zhu J; Gao HQ; Yin J; Wang W; Tian ML
PLoS One; 2012; 7(9):e44618. PubMed ID: 22957090
[TBL] [Abstract][Full Text] [Related]
6. SPARC overexpression inhibits cell proliferation in neuroblastoma and is partly mediated by tumor suppressor protein PTEN and AKT.
Bhoopathi P; Gorantla B; Sailaja GS; Gondi CS; Gujrati M; Klopfenstein JD; Rao JS
PLoS One; 2012; 7(5):e36093. PubMed ID: 22567126
[TBL] [Abstract][Full Text] [Related]
7. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
8. SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells.
Zhang J; Wang P; Zhu J; Wang W; Yin J; Zhang C; Chen Z; Sun L; Wan Y; Wang X; Chen G; Liu Y
Oncol Rep; 2014 May; 31(5):2312-20. PubMed ID: 24676680
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.
Chlenski A; Guerrero LJ; Peddinti R; Spitz JA; Leonhardt PT; Yang Q; Tian Y; Salwen HR; Cohn SL
Mol Cancer; 2010 Jun; 9():138. PubMed ID: 20525313
[TBL] [Abstract][Full Text] [Related]
11. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis.
Funahashi Y; Hernandez SL; Das I; Ahn A; Huang J; Vorontchikhina M; Sharma A; Kanamaru E; Borisenko V; Desilva DM; Suzuki A; Wang X; Shawber CJ; Kandel JJ; Yamashiro DJ; Kitajewski J
Cancer Res; 2008 Jun; 68(12):4727-35. PubMed ID: 18559519
[TBL] [Abstract][Full Text] [Related]
12. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
[TBL] [Abstract][Full Text] [Related]
13. The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.
Bhoopathi P; Chetty C; Gujrati M; Dinh DH; Rao JS; Lakka SS
Br J Cancer; 2010 Feb; 102(3):530-40. PubMed ID: 20087345
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
15. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
Guo S; Gonzalez-Perez RR
PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
[TBL] [Abstract][Full Text] [Related]
16. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
[TBL] [Abstract][Full Text] [Related]
17. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
Chlenski A; Liu S; Guerrero LJ; Yang Q; Tian Y; Salwen HR; Zage P; Cohn SL
Int J Cancer; 2006 Jan; 118(2):310-6. PubMed ID: 16052522
[TBL] [Abstract][Full Text] [Related]
18. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
19. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
Bäckman U; Christofferson R
Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357
[TBL] [Abstract][Full Text] [Related]
20. Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids.
Chlenski A; Dobratic M; Salwen HR; Applebaum M; Guerrero LJ; Miller R; DeWane G; Solomaha E; Marks JD; Cohn SL
Oncotarget; 2016 Nov; 7(47):77696-77706. PubMed ID: 27776337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
